Filing Flows

Filing Flows › Profound Medical (PROF) › Next earnings date

Profound Medical (PROF) earnings: missed the estimate

Profound Medical (PROF) reported on Nov 5, 2026 and missed the EPS estimate: −$0.21 against −$0.20 (-7.7%). Revenue was $9.8M for Q3 2026, +86% year over year. It beat the EPS estimate in 60% of the quarters on record.

Last result−7.7% vs estimate
Beat rate60%

The last report

Profound Medical reported revenue of $9.8M for the third quarter 2026 (+86% Y/Y), net loss $7.7M: Capital equipment $5.7M, Recurring - non-capital $4.1M. How it makes money → · Every quarter →

Profound Medical: EPS against the estimate, last 5 reportsProfound Medical: EPS against the estimate, last 5 reportsEstimateReported−$0.38−$0.26Nov 25−$0.27−$0.27Mar 26−$0.25−$0.19May 26−$0.24−$0.26Aug 26−$0.20−$0.21Nov 26
Latest (Nov 26): Estimate −$0.20, Reported −$0.21.
PROF: the stock's move on each reportPROF: the stock's move on each reportAug 6, 2026-7.3%May 7, 2026-5.1%Mar 5, 2026-29.0%Nov 13, 2025+5.9%

Profound Medical's latest quarter

Profound Medical, Q3 2026: revenue $9.8M (+86% year over year), operating margin -79.6%, net loss $7.7M, operating cash flow −$5.0M. The chart follows the revenue to costs, profit and cash.

Questions

Did Profound Medical beat earnings?

Profound Medical (PROF) reported on Nov 5, 2026 and missed the EPS estimate: −$0.21 against −$0.20 (-7.7%).

When does PROF report earnings?

The next date is not set yet.

Does Profound Medical usually beat earnings?

It beat the consensus EPS estimate in 60% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.